Pertussis Epidemiology Forecast 2025-2034

Pertussis is a bacterial infection which affects the lungs and causes severe coughing fits. It is highly contagious and spreads through droplets from coughing and sneezing. According to the Centers for Disease Control and Prevention (CDC), there are approximately 24.1 million cases of whooping cough and approximately 160,700 deaths in children younger than age 5 years of age, every year, globally.

Pertussis Epidemiology Forecast Report Coverage

The “Pertussis Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of pertussis. It projects the future incidence and prevalence rates of pertussis across various populations. The study covers age, gender, and type as major determinants of the pertussis-affected population. The report highlights patterns in the prevalence of pertussis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of pertussis in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Pertussis Disease Overview

Pertussis is a highly contagious respiratory disease which is caused by the bacterium called Bordetella pertussis . It is also known as whooping cough. The disease primarily affects infants and young children but can also occur in adolescents and adults. The disease begins with minor symptoms like runny nose, sneezing, and mild cough progressing to severe coughing creating a "whooping" sound, vomiting, and exhaustion. Severe complications are seen in infants, potentially leading to pneumonia, brain damage, or even death in severe cases. The disease is highly contagious, especially in the early stages.

Pertussis: Treatment Overview

The treatment of pertussis depends on the severity of symptoms. The primary treatment includes antibiotics, particularly macrolides such as azithromycin or clarithromycin. The treatment is most effective when administered during an early stage of the disease as these antibiotics are less effective in reducing symptoms during the later stages of the disease. Supportive care plays an important role, especially in infants and young children which includes ensuring proper hydration, and providing oxygen if needed. Hospitalization may be necessary in case of severe cases. To prevent secondary cases, vaccination of close contacts and prophylactic antibiotics may also be recommended.

Epidemiology

The pertussis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for Pertussis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for pertussis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to the UK Health Security Agency (UKHSA), approximately 14,727 laboratory-confirmed cases of pertussis were reported between January and November 2024.
• According to the Ministry of Health and Family Welfare, India, in 2018, 13,208 cases of pertussis were reported in India.
• According to the European Centre for Disease Prevention and Control, Germany accounted for 45% of all reported cases among 29 EU countries.
• According to the National Health Institute, in 2024, France experienced a resurgence of pertussis. Approximately 5,616 positive Bordetella pertussis qPCR tests were identified in France between January 1 st and May 31 st, 2024.

Country-wise Pertussis Epidemiology

The pertussis epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

Pertussis remains a significant public health concern globally with variations in the number of cases and control measures across countries. According to the Centers for Disease Control, 10,000 cases are typically reported each year in the United States as the country is beginning to return to pre-pandemic patterns of disease. According to the UK government, 10 deaths occurred in infants due to pertussis between the period of January and November 2024.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of pertussis based on several factors.
• Pertussis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of pertussis are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of pertussis epidemiology in the 8 major markets?
• What will be the total number of patients with pertussis across the 8 major markets during the forecast period?
• What was the country-wise prevalence of pertussis in the 8 major markets in the historical period?
• Which country will have the highest number of pertussis patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of pertussis during the forecast period of 2025-2034?
• What are the currently available treatments for pertussis?
• What are the disease risks, signs, symptoms, and unmet needs of pertussis?

This product will be delivered within 3-5 business days.